The latter may contain MYC and BCL2 and/or BCL6 rearrangements (“double-hit” or “triple-hit” lymphomas) and they usually have an aggressive clinical course and a worse prognosis than BL [1,5]. The gene discussed is BCL2; the disease is Burkitt lymphoma.